DOI: https://doi.org/10.14710/dmj.v13i3.43369

The effect combination of black seed (nigella sativa) and glibenclamide on blood glucose levels

*Erika Martining Wardani orcid scopus publons  -  Departemen of Nursing, Faculty of Nursing and Midwifery, Universitas Nahdlatul Ulama Surabaya, 60237 Surabaya, East Java, Indonesia, Indonesia
Riezky Faisal Nugroho orcid scopus  -  Departemen of Nutrition, Politeknik Kesehatan Kemenkes Surabaya, 60282 Surabaya, East Java Indonesia, Indonesia

Citation Format:
Abstract

Background: Diabetes Mellitus was considered one of the most alarming pandemics of the twenty-first century before the advent of the COVID-19 pandemic. Glibenclamide (glyburide) is an anti-DM drug of the sulfonylurea class. Several studies have examined one of the medicinal plants, black seed (nigella sativa) as a complementary treatment in the control of DM.

Objective: This study determine the effect of the combination of black seed (nigella sativa) and glibenclamide on reducing blood glucose levels.

Methods: This research design was an experiment using a pretest posttest design with control group design. This study used 24 mice (mus muscullus) which were divided into 4 groups, namely a negative control group that was only given aquadest, a positive control group that was given alloxane as an induction of hyperglycemia and anti-DM drug glibenclamide, treatment group 1 was given aloxane and Black Seed, and treatment group 2 was given alloxane and a combination of black seed and glibenclamid. Data were analyzed using the Paired T Test with α = 0.05.

Results: Blood glucose levels in the black seed and glibenclamid combination treatment group decreased significantly (p=0,00).

Conclusion: the combination of black seed (nigella sativa) and glibenclamide is effective in lowering glucose levels.

Fulltext View|Download
Keywords: effect, Nigella sativa, glibenclamide, blood glucose levels

Article Metrics:

Article Info
Section: Original Articles
Language : EN
Recent articles
Evaluation of the Quantity and Quality of Antibiotic Use in Inpatient Pediatric Urinary Tract Infection (UTI) Patients at RSUD KRMT Wongsonegoro Semarang Correlation between TGF-β Levels and Degree of Wound Healing in Leprosy Ulcer Patients: An Observational Study at dr. Rehatta Regional Hospital Jepara Correlation between Degree of Leprosy Disability and Serum IL-6 Levels in Patients with Leprosy Reactions: An Observational Study at the Donorojo Jepara Leprosy Hospital Center More recent articles
  1. International Diabetes Federation (IDF). IDF international atlas 10th edition (online) 2021 (diakses 14 Maret 2023)
  2. Wardani EM, Nugroho RF, Bistara DN, Wijayanti L., Nurhasina S. Characteristics, Clinical Manifestations, Length of Hospitalization and Nutritional Status of COVID-19 patients. Journal Infectology. 2023; 15(2): 68-73. https://doi.org/10.22625/2072-6732-2023-15-2-68-73
  3. Vieira R, Souto SB, Sánchez-López E, Machado AL, Severino P, Jose S, Santini A, Fortuna A, García ML, Silva AM, Souto EB. Sugar-Lowering Drugs for Type 2 Diabetes Mellitus and Metabolic Syndrome-Review of Classical and New Compounds: Part-I. Pharmaceuticals (Basel). 2019 Oct 10;12(4):152. doi: 10.3390/ph12040152
  4. Xu Y, Yang Z, Lin H, Shen P, Wang H, Zhan S. Long-Term Patterns of Antidiabetic Medication Use in Patients with Type 2 Diabetes. Med Sci Monit. 2018 Dec 2; 24:8707-8715. doi: 10.12659/MSM.913603
  5. Chaturvedi R, Desai C, Patel P, Shah A, Dikshit RK. An evaluation of the impact of antidiabetic medication on treatment satisfaction and quality of life in patients of diabetes mellitus. Perspect Clin Res. 2018 Jan-Mar; 9(1):15-22. doi: 10.4103/picr.PICR_140_16
  6. Nachum Z, Zafran N, Salim R, Hissin N, Hasanein J, Ze Letova YM, et al. Glyburide versus metformin and their combination for the treatment of gestational diabetes mellitus: a randomized controlled study. Diabetes Care 2017; 40(3):332-7. https://doi.org/10.2337/dc16-2307 30
  7. Ridhayani F, et al, Comparison between metformin ... 14. Reynolds RM, Denison FC, Juszczak E, Bell JL, Penneycard J, Strachan MWJ, et al. Glibenclamide and metfoRmin versus stAndard care in gEstational diabeteS (GRACES): a feasibility open label randomised trial. BMC Pregnancy Childbirth 2017; 17(1):316. https://doi.org/10.1186/s12884-017-1505-3
  8. Guo L, Ma J, Tang J, Hu D, Zhang W, Zhao X. Comparative efficacy and safety of metformin, glyburide, and insulin in treating gestational diabetes mellitus: a meta-analysis. J Diabetes Res 2019; 2019:9804708. https://doi.org/10.1155/2019/9804708
  9. Wardani, E. M., Nugroho, R. F., Setiyowati, E., Khafid, M., & Purwanti, N. (2023). Effectiveness of Health Management Education for Congestive Heart Failure Patients in Surabaya. South East European Journal of Cardiology, 4(1), 18-21. https://doi.org/10.3889/seejca.2023.6041
  10. Hematyar J, Rashidi H, Zakerkish M, Payami SP, Ghaderian SB. Effect of Sitagliptin Versus Glibenclamide on Glycemic Markers, Lipid Profile Inflammatory and Oxidative Stress Factors in Type 2 Diabetes Patients: a Double-Blinded Randomized Controlled Trial. Maedica (Bucur). 2022 Dec;17(4):762-770. doi: 10.26574/maedica.2022.17.4.762
  11. Maideen NMP. Antidiabetic Activity of Nigella Sativa (Black Seeds) and Its Active Constituent (Thymoquinone): A Review of Human and Experimental Animal Studies. Chonnam Med J. 2021 Sep; 57(3):169-175. doi: 10.4068/cmj.2021.57.3.169
  12. Hamdan A, Haji Idrus R, Mokhtar MH. Effects of Nigella Sativa on Type-2 Diabetes Mellitus: A Systematic Review. Int J Environ Res Public Health. 2019 Dec 5; 16(24):4911. doi: 10.3390/ijerph16244911
  13. Marín-Aguilar F, Pavillard LE, Giampieri F, Bullón P, Cordero MD. Adenosine Monophosphate (AMP)-Activated Protein Kinase: A New Target for Nutraceutical Compounds. Int J Mol Sci. 2017 Jan 29; 18(2):288. doi: 10.3390/ijms18020288
  14. Wardani, E. M., Zahroh, C., & Ainiyah, N. (2019). Diabetic Foot Spa Implementation in Early Neuropathy Diagnosis Based on Blood Glucose Levels, Foot Sensitivity and the Ankle Brachial Index in Patients with Diabetes Mellitus. Jurnal Ners, 14(1), 106-110. https://doi.org/10.20473/jn.v14i1.9950
  15. Wardani, E. M., & Nugroho, R. F. (2023). The Correlation Lifestyle with the Incidence of Diabetes Mellitus Type 2. Jurnal Kedokteran Diponegoro (Diponegoro Medical Journal): JKD, 12(3), 119-123. https://doi.org/10.14710/dmj.v12i3.37822
  16. Shaukat A, Zaidi A, Anwar H, Kizilbash N. Mechanism of the antidiabetic action of Nigella sativa and Thymoquinone: a review. Front Nutr. 2023 Sep 25;10:1126272. doi: 10.3389/fnut.2023.1126272
  17. Ali SM, Chen P, Sheikh S, Ahmad A, Ahmad M, Paithankar M, Desai B, Patel P, Khan M, Chaturvedi A, Patel R, Panchal DT, Shah K, Chavda V, Saboo BD, Patel A, Ahmad I. Thymoquinone with Metformin Decreases Fasting, Post Prandial Glucose, and HbA1c in Type 2 Diabetic Patients. Drug Res (Stuttg). 2021 Jul;71(6):302-306. doi: 10.1055/a-1388-5415
  18. Moustafa HAM, El Wakeel LM, Halawa MR, Sabri NA, El-Bahy AZ, Singab AN. Effect of Nigella Sativa oil versus metformin on glycemic control and biochemical parameters of newly diagnosed type 2 diabetes mellitus patients. Endocrine. 2019 Aug;65(2):286-294. doi: 10.1007/s12020-019-01963-4
  19. Mahomoodally MF, Aumeeruddy MZ, Legoabe LJ, Montesano D, Zengin G. Nigella sativa L. and Its Active Compound Thymoquinone in the Clinical Management of Diabetes: A Systematic Review. Int J Mol Sci. 2022 Oct 11; 23(20):12111. doi: 10.3390/ijms232012111
  20. Hamdan A, Haji Idrus R, Mokhtar MH. Effects of Nigella Sativa on Type-2 Diabetes Mellitus: A Systematic Review. Int J Environ Res Public Health. 2019 Dec 5;16(24):4911. doi: 10.3390/ijerph16244911
  21. Hoda F, Khanam A, Thareja M, Arshad M, Ahtar M, Najmi AK. Effect of Nigella Sativa in Improving Blood Glucose Level in T2DM: Systematic Literature Review of Randomized Control Trials. Drug Res (Stuttg). 2023 Jan;73(1):17-22. doi: 10.1055/a-1936-8412
  22. Soleimani-Dodran M, Alipanah-Moghadam R, Jeddi F, Babaei M, Salimnejad R, Bahreini E. Effect of hydroalcoholic seed extract of Nigella sativa on hepatic and pancreatic factors of Nrf2 and FGF21 in the regulation of insulin transcription factors of MafA and PDX-1 in streptozotocin-treated diabetic rats. Nutr Metab (Lond). 2022 Sep 15; 19(1):64. doi: 10.1186/s12986-022-00699-9
  23. Kaatabi H, Bamosa AO, Badar A, Al-Elq A, Abou-Hozaifa B, Lebda F, Al-Khadra A, Al-Almaie S. Nigella sativa improves glycemic control and ameliorates oxidative stress in patients with type 2 diabetes mellitus: placebo controlled participant blinded clinical trial. PLoS One. 2015 Feb 23; 10(2):e0113486. doi: 10.1371/journal.pone.0113486
  24. Shaukat A, Zaidi A, Anwar H, Kizilbash N. Mechanism of the antidiabetic action of Nigella sativa and Thymoquinone: a review. Front Nutr. 2023 Sep 25; 10:1126272. doi: 10.3389/fnut.2023.1126272
  25. Basile G, Qadir MMF, Mauvais-Jarvis F, Vetere A, Shoba V, Modell AE, Pastori RL, Russ HA, Wagner BK, Dominguez-Bendala J. Emerging diabetes therapies: Bringing back the β-cells. Mol Metab. 2022 Jun;60:101477. doi: 10.1016/j.molmet.2022.101477
  26. Leisegang K, Almaghrawi W, Henkel R. The effect of Nigella sativa oil and metformin on male seminal parameters and testosterone in Wistar rats exposed to an obesogenic diet. Biomed Pharmacother. 2021 Jan;133:111085. doi: 10.1016/j.biopha.2020.111085
  27. Fadishei M, Ghasemzadeh Rahbardar M, Imenshahidi M, Mohajeri A, Razavi BM, Hosseinzadeh H. Effects of Nigella sativa oil and thymoquinone against bisphenol A-induced metabolic disorder in rats. Phytother Res. 2021 Apr; 35(4):2005-2024. doi: 10.1002/ptr.6944

Last update:

No citation recorded.

Last update:

No citation recorded.